BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mengel M, Loupy A, Haas M, Roufosse C, Naesens M, Akalin E, Clahsen-van Groningen MC, Dagobert J, Demetris AJ, Duong van Huyen JP, Gueguen J, Issa F, Robin B, Rosales I, Von der Thüsen JH, Sanchez-Fueyo A, Smith RN, Wood K, Adam B, Colvin RB. Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation-Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation. Am J Transplant 2020;20:2305-17. [PMID: 32428337 DOI: 10.1111/ajt.16059] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Boud'hors C, Copin MC, Wacrenier S, Piccoli GB, Croue A, Augusto JF, Brilland B. Histopathological prognostic factors in ANCA-associated glomerulonephritis. Autoimmun Rev 2022;21:103139. [PMID: 35835443 DOI: 10.1016/j.autrev.2022.103139] [Reference Citation Analysis]
2 Hesselink DA, Hullegie-Peelen DM, van Vugt LK. Personalized anti-rejection therapy with alemtuzumab for kidney transplant recipients. Pharmacogenomics 2022. [PMID: 35763447 DOI: 10.2217/pgs-2022-0071] [Reference Citation Analysis]
3 McCloskey C, Zubrycki M, Lawrence C. The Molecular Microscope Diagnostic System (MMDx) interpretation of solid organ allograft biopsies: Restoring the perspective. Clin Transplant 2022;:e14711. [PMID: 35668041 DOI: 10.1111/ctr.14711] [Reference Citation Analysis]
4 El Sabagh A, Mohamed IB, Aloor FZ, Abdelwahab A, Hassan MM, Jalal PK. Current Status of Biomarkers and Molecular Diagnostic Tools for Rejection in Liver Transplantation: Light at the end of the Tunnel? Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.06.010] [Reference Citation Analysis]
5 Kant S, Brennan DC. Donor Derived Cell Free DNA in Kidney Transplantation: The Circa 2020–2021 Update. Transpl Int 2022;35:10448. [DOI: 10.3389/ti.2022.10448] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 van Baardwijk M, Cristoferi I, Ju J, Varol H, Minnee RC, Reinders MEJ, Li Y, Stubbs AP, Clahsen-van Groningen MC. A Decentralized Kidney Transplant Biopsy Classifier for Transplant Rejection Developed Using Genes of the Banff-Human Organ Transplant Panel. Front Immunol 2022;13:841519. [PMID: 35619722 DOI: 10.3389/fimmu.2022.841519] [Reference Citation Analysis]
7 Becker JU, Seron D, Rabant M, Roufosse C, Naesens M. Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials. Transpl Int 2022;35:10141. [DOI: 10.3389/ti.2022.10141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zee J, Liu Q, Smith AR, Hodgin JB, Rosenberg A, Gillespie BW, Holzman LB, Barisoni L, Mariani LH; Nephrotic Syndrome Study Network (NEPTUNE). Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis. J Am Soc Nephrol 2022:ASN. [PMID: 35581011 DOI: 10.1681/ASN.2021101396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Taner T, Bruner J, Emamaullee J, Bonaccorsi-Riani E, Zarrinpar A. New Approaches to the Diagnosis of Rejection and Prediction of Tolerance in Liver Transplantation. Transplantation 2022. [PMID: 35594482 DOI: 10.1097/TP.0000000000004160] [Reference Citation Analysis]
10 Halloran PF, Böhmig GA, Bromberg J, Einecke G, Eskandary FA, Gupta G, Myslak M, Viklicky O, Perkowska-Ptasinska A, Madill-Thomsen KS; INTERCOMEX Investigators. Archetypal Analysis of Injury in Kidney Transplant Biopsies Identifies Two Classes of Early AKI. Front Med (Lausanne) 2022;9:817324. [PMID: 35463013 DOI: 10.3389/fmed.2022.817324] [Reference Citation Analysis]
11 Vonbrunn E, Angeloni M, Büttner-Herold M, Müller-Deile J, Heller K, Bleich E, Söllner S, Amann K, Ferrazzi F, Daniel C. Can Gene Expression Analysis in Zero-Time Biopsies Predict Kidney Transplant Rejection? Front Med (Lausanne) 2022;9:793744. [PMID: 35433772 DOI: 10.3389/fmed.2022.793744] [Reference Citation Analysis]
12 Silva T, Voisey J, Hopkins P, Apte S, Chambers D, O'Sullivan B. Markers of rejection of a lung allograft: state of the art. Biomark Med 2022;16:483-98. [PMID: 35315284 DOI: 10.2217/bmm-2021-1013] [Reference Citation Analysis]
13 Gambella A, Mastracci L, Caporalini C, Francalanci P, Mescoli C, Ferro J, Alaggio R, Grillo F. Not only a small liver - The pathologist's perspective in the pediatric liver transplant setting. Pathologica 2022;114:89-103. [PMID: 35212319 DOI: 10.32074/1591-951X-753] [Reference Citation Analysis]
14 Westphal SG, Mannon RB. Emerging biomarkers in kidney transplantation and challenge of clinical implementation. Curr Opin Organ Transplant 2022;27:15-21. [PMID: 34939960 DOI: 10.1097/MOT.0000000000000941] [Reference Citation Analysis]
15 Kurian S, Friedewald J. Comparing Plasma Donor-Derived Cell-free DNA to Indication Kidney Biopsy Tissue Gene Expression: Toward Understanding the Molecular Equivalents of Non-Invasive Tests. JASN. [DOI: 10.1681/asn.2021121595] [Reference Citation Analysis]
16 Jang H, Bae S, Ko Y, Lim SJ, Kwon HE, Jung JH, Cho HY, Go H, Kwon H, Kim YH, Kim S, Shin S. Acute T cell-mediated rejection after administration of the BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient: a case report. Korean J Transplant 2021;35:253-6. [DOI: 10.4285/kjt.21.0025] [Reference Citation Analysis]
17 Novotný M, Kment M, Viklický O. Adipose tissue macrophages and atherogenesis – a synergy with cholesterolaemia. Physiol Res 2021. [DOI: 10.33549//physiolres.934801] [Reference Citation Analysis]
18 Callemeyn J, Lamarthée B, Koenig A, Koshy P, Thaunat O, Naesens M. Allorecognition and the spectrum of kidney transplant rejection. Kidney Int 2021:S0085-2538(21)01143-1. [PMID: 34915041 DOI: 10.1016/j.kint.2021.11.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
19 Loupy A, Mengel M, Haas M. 30 years of the International Banff Classification for Allograft Pathology: The Past, Present and Future of Kidney Transplant Diagnostics. Kidney International 2021. [DOI: 10.1016/j.kint.2021.11.028] [Reference Citation Analysis]
20 Filippone EJ, Gulati R, Farber JL. Noninvasive Assessment of the Alloimmune Response in Kidney Transplantation. Adv Chronic Kidney Dis 2021;28:548-60. [PMID: 35367023 DOI: 10.1053/j.ackd.2021.08.002] [Reference Citation Analysis]
21 Rampersad C, Balshaw R, Gibson IW, Ho J, Shaw J, Karpinski M, Goldberg A, Birk P, Rush DN, Nickerson PW, Wiebe C. The negative impact of T cell-mediated rejection on renal allograft survival in the modern era. Am J Transplant 2021. [PMID: 34717048 DOI: 10.1111/ajt.16883] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Gambella A, Barreca A, Osella-Abate S, Bottasso E, Giarin MM, Papotti M, Biancone L, Metovic J, Collemi G, Cassoni P, Bertero L. Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel. Biomedicines 2021;9:1318. [PMID: 34680435 DOI: 10.3390/biomedicines9101318] [Reference Citation Analysis]
23 Salem F, Perin L, Sedrakyan S, Angeletti A, Ghiggeri GM, Coccia MC, Ross M, Fribourg M, Cravedi P. The spatially resolved transcriptional profile of acute T cell-mediated rejection in a kidney allograft. Kidney Int 2021:S0085-2538(21)00864-4. [PMID: 34555393 DOI: 10.1016/j.kint.2021.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
24 Mantell BS, Cordero H, See SB, Clerkin KJ, Vasilescu R, Marboe CC, Naka Y, Restaino S, Colombo PC, Addonizio LJ, Farr MA, Zorn E. Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodies. J Heart Lung Transplant 2021;40:1472-80. [PMID: 34420852 DOI: 10.1016/j.healun.2021.06.012] [Reference Citation Analysis]
25 Bloom RD, Augustine JJ. Beyond the Biopsy: Monitoring Immune Status in Kidney Recipients. Clin J Am Soc Nephrol 2021:CJN. [PMID: 34362810 DOI: 10.2215/CJN.14840920] [Reference Citation Analysis]
26 Mengel M, Lubetzky M. Do we need to treat chronic active T cell-mediated rejection? Kidney Int 2021;100:275-7. [PMID: 34294207 DOI: 10.1016/j.kint.2021.04.031] [Reference Citation Analysis]
27 Kung VL, Sandhu R, Haas M, Huang E. Chronic active T cell–mediated rejection is variably responsive to immunosuppressive therapy. Kidney International 2021;100:391-400. [DOI: 10.1016/j.kint.2021.03.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Vonbrunn E, Ries T, Söllner S, Müller-Deile J, Büttner-Herold M, Amann K, Daniel C. Multiplex gene analysis reveals T-cell and antibody-mediated rejection-specific upregulation of complement in renal transplants. Sci Rep 2021;11:15464. [PMID: 34326417 DOI: 10.1038/s41598-021-94954-3] [Reference Citation Analysis]
29 Kurian SM, Whisenant TC, Marsh CL. Toward Improved and Standardized Diagnostic Pipelines in Transplantation. Transplantation 2021;105:12-3. [PMID: 33350625 DOI: 10.1097/TP.0000000000003438] [Reference Citation Analysis]
30 Filippone EJ, Farber JL. The Problem of Subclinical Antibody-mediated Rejection in Kidney Transplantation. Transplantation 2021;105:1176-87. [PMID: 33196628 DOI: 10.1097/TP.0000000000003543] [Reference Citation Analysis]
31 Kurian SM, Whisenant TC, Marsh CL. Systems biology approaches in solid organ transplantation. Curr Opin Organ Transplant 2021;26:37-42. [PMID: 33315768 DOI: 10.1097/MOT.0000000000000837] [Reference Citation Analysis]
32 Hirai T, Mayer AT, Nobashi TW, Lin PY, Xiao Z, Udagawa T, Seo K, Simonetta F, Baker J, Cheng AG, Negrin RS, Gambhir SS. Imaging alloreactive T cells provides early warning of organ transplant rejection. JCI Insight 2021;6:145360. [PMID: 34236044 DOI: 10.1172/jci.insight.145360] [Reference Citation Analysis]
33 Veta M, van Diest PJ, Vink A. Can automatic image analysis replace the pathologist in cardiac allograft rejection diagnosis? Eur Heart J 2021;42:2370-2. [PMID: 34000014 DOI: 10.1093/eurheartj/ehab226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Del Bello A, Marion O, Delas A, Congy-Jolivet N, Colombat M, Kamar N. Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant. Kidney Int 2021;100:238-9. [PMID: 33932459 DOI: 10.1016/j.kint.2021.04.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Vasquez-Rios G, Menon MC. Kidney Transplant Rejection Clusters and Graft Outcomes: Revisiting Banff in the Era of "Big Data". J Am Soc Nephrol 2021;32:1009-11. [PMID: 33824191 DOI: 10.1681/ASN.2021030348] [Reference Citation Analysis]
36 Stark HL, Wang HC, Kuburic J, Alzhrani A, Hester J, Issa F. Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When? Front Immunol 2021;12:664244. [PMID: 33841448 DOI: 10.3389/fimmu.2021.664244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Smith RN. In-silico performance, validation, and modeling of the Nanostring Banff Human Organ transplant gene panel using archival data from human kidney transplants. BMC Med Genomics 2021;14:86. [PMID: 33740956 DOI: 10.1186/s12920-021-00891-5] [Reference Citation Analysis]
38 Mengel M, Mannon RB. Banff and ABMR: Are we going in the right direction? Am J Transplant 2021;21:2321-2. [PMID: 33621422 DOI: 10.1111/ajt.16546] [Reference Citation Analysis]
39 Hoogduijn MJ, Issa F, Casiraghi F, Reinders MEJ. Cellular therapies in organ transplantation. Transpl Int 2021;34:233-44. [PMID: 33207013 DOI: 10.1111/tri.13789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Rabant M, Coutance G, Isnard P, Duong-Van-Huyen JP. [Pathology of heart transplantation: Where are we now?]. Ann Pathol 2021;41:38-49. [PMID: 33413972 DOI: 10.1016/j.annpat.2020.12.001] [Reference Citation Analysis]
41 Honeyman C, Stark H, Wang HC, Hester J, Issa F, Giele H. Biomarker and surrogate development in vascularised composite allograft transplantation: Current progress and future challenges. J Plast Reconstr Aesthet Surg 2021;74:711-7. [PMID: 33436335 DOI: 10.1016/j.bjps.2020.11.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Smith RN, Colvin RB. Prediction is hard, especially regarding the futurea. Am J Transplant 2021;21:1357-8. [PMID: 32713099 DOI: 10.1111/ajt.16220] [Reference Citation Analysis]
43 Mengel M, Loupy A, Haas M, Roufosse C, Naesens M, Akalin E, Clahsen-van Groningen MC, Dagobert J, Demetris AJ, Duong van Huyen JP, Gueguen J, Issa F, Robin B, Rosales I, Von der Thüsen JH, Sanchez-Fueyo A, Smith RN, Wood K, Adam B, Colvin RB. Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation-Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation. Am J Transplant 2020;20:2305-17. [PMID: 32428337 DOI: 10.1111/ajt.16059] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 23.0] [Reference Citation Analysis]
44 Wu H, Larsen CP, Hernandez-Arroyo CF, Mohamed MMB, Caza T, Sharshir M, Chughtai A, Xie L, Gimenez JM, Sandow TA, Lusco MA, Yang H, Acheampong E, Rosales IA, Colvin RB, Fogo AB, Velez JCQ. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype. J Am Soc Nephrol. 2020;31:1688-1695. [PMID: 32561682 DOI: 10.1681/asn.2020050558] [Cited by in Crossref: 81] [Cited by in F6Publishing: 62] [Article Influence: 40.5] [Reference Citation Analysis]